↓ Skip to main content

Elucidating immunologic mechanisms of PROSTVAC cancer immunotherapy

Overview of attention for article published in Journal for Immunotherapy of Cancer, October 2014
Altmetric Badge

Citations

dimensions_citation
14 Dimensions

Readers on

mendeley
51 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Elucidating immunologic mechanisms of PROSTVAC cancer immunotherapy
Published in
Journal for Immunotherapy of Cancer, October 2014
DOI 10.1186/s40425-014-0034-0
Pubmed ID
Authors

Stefanie J Mandl, Ryan B Rountree, Tracy B dela Cruz, Susan P Foy, Joseph J Cote, Evan J Gordon, Erica Trent, Alain Delcayre, Alex Franzusoff

Abstract

PROSTVAC®, an active immunotherapy currently studied for the treatment of metastatic castration-resistant prostate cancer (mCRPC), consists of a heterologous prime-boost regimen with two different poxvirus-based vectors to provoke productive immune responses against prostate specific antigen (PSA) as the target tumor antigen. A Phase 2 study of PROSTVAC immunotherapy showed significantly improved median overall survival by 8.5 months and is currently being validated in a global Phase 3 study (PROSPECT; NCT01322490). Here, preclinical models were explored to investigate the mechanism of action and immune signatures of anti-tumor efficacy with PROSTVAC immunotherapy with the goal to identify potential immune correlates of clinical benefit.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 51 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 2%
France 1 2%
Unknown 49 96%

Demographic breakdown

Readers by professional status Count As %
Researcher 14 27%
Student > Master 8 16%
Student > Bachelor 6 12%
Student > Ph. D. Student 5 10%
Professor 2 4%
Other 7 14%
Unknown 9 18%
Readers by discipline Count As %
Medicine and Dentistry 17 33%
Agricultural and Biological Sciences 8 16%
Immunology and Microbiology 8 16%
Biochemistry, Genetics and Molecular Biology 4 8%
Earth and Planetary Sciences 1 2%
Other 3 6%
Unknown 10 20%